126 related articles for article (PubMed ID: 15130536)
1. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells.
Trybala E; Olofsson S; Mårdberg K; Svennerholm B; Umemoto K; Glorioso JC; Bergström T
Antiviral Res; 2004 Jun; 62(3):125-34. PubMed ID: 15130536
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
3. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
Herold BC; Spear PG
Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
[TBL] [Abstract][Full Text] [Related]
4. Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity.
Mårdberg K; Nyström K; Tarp MA; Trybala E; Clausen H; Bergström T; Olofsson S
Glycobiology; 2004 Jul; 14(7):571-81. PubMed ID: 15044392
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
6. Evidence for an interaction of herpes simplex virus with chondroitin sulfate proteoglycans during infection.
Banfield BW; Leduc Y; Esford L; Visalli RJ; Brandt CR; Tufaro F
Virology; 1995 Apr; 208(2):531-9. PubMed ID: 7747425
[TBL] [Abstract][Full Text] [Related]
7. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.
Herold BC; Gerber SI; Polonsky T; Belval BJ; Shaklee PN; Holme K
Virology; 1995 Feb; 206(2):1108-16. PubMed ID: 7856085
[TBL] [Abstract][Full Text] [Related]
8. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
9. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate.
Trybala E; Bergström T; Svennerholm B; Jeansson S; Glorioso JC; Olofsson S
J Gen Virol; 1994 Apr; 75 ( Pt 4)():743-52. PubMed ID: 7512117
[TBL] [Abstract][Full Text] [Related]
10. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
Akula SM; Pramod NP; Wang FZ; Chandran B
Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
[TBL] [Abstract][Full Text] [Related]
11. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
12. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
13. Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion.
Gianni T; Piccoli A; Bertucci C; Campadelli-Fiume G
J Virol; 2006 Mar; 80(5):2216-24. PubMed ID: 16474129
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.
Trybala E; Liljeqvist JA; Svennerholm B; Bergström T
J Virol; 2000 Oct; 74(19):9106-14. PubMed ID: 10982357
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells.
Mårdberg K; Trybala E; Tufaro F; Bergström T
J Gen Virol; 2002 Feb; 83(Pt 2):291-300. PubMed ID: 11807221
[TBL] [Abstract][Full Text] [Related]
16. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
17. A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.
Gianni T; Menotti L; Campadelli-Fiume G
J Virol; 2005 Jun; 79(11):7042-9. PubMed ID: 15890943
[TBL] [Abstract][Full Text] [Related]
18. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.
Adamiak B; Trybala E; Mardberg K; Johansson M; Liljeqvist JA; Olofsson S; Grabowska A; Bienkowska-Szewczyk K; Szewczyk B; Bergstrom T
Virology; 2010 May; 400(2):197-206. PubMed ID: 20176392
[TBL] [Abstract][Full Text] [Related]
19. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
Herold BC; Visalli RJ; Susmarski N; Brandt CR; Spear PG
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1211-22. PubMed ID: 8207388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
